Green Light and Transcranial Direct Current Stimulation in Migraine Patients
- Disease/Condition
- Migraine
- Drug/Device/Intervention
- Transcranial direct current stimulation
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Riphah International University
- Location
- Rawalpindi, Pakistan
- Phase
- N/A
- Start date
- Jan 18, 2024
- End date
- Oct 31, 2024
- Enrollment
- 45 participants
Structured Headache Diary Data for frequency of migraine,Numeric Pain Scale (NPS) for intensity of migraine,Multidimensional pain inventory (MPI) for migraine impact
There is a lack of evidence on the clinical outcome of green light exposure, as it is the
 emerging, novel proposal of treatment. There are a lot of researches present with small
 sample size which should be done on large population. In last conducted studies, session
 numbers of the applied modality are less. There is no comparison of tDCS with green light for
 migraine. The literature suggested the neuromodulation influenced by these interventions that
 may result in reduction of migraine.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06212869
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06212869 through Pure Global AI's free database. This phase not specified trial is sponsored by Riphah International University and is currently Recruiting. The study focuses on Migraine. Target enrollment is 45 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.